Anika Therapeutics Inc (ANIK)

03:23 AM

Anika Therapeutics, Inc. (NASDAQ:ANIK) Position Trimmed by HighTower Advisors LLC - Defense World

03:23 AM

Apr 03, 2025

Are Options Traders Betting on a Big Move in Anika Therapeutics (ANIK) Stock? - TradingView

Apr 03, 2025

Apr 02, 2025

Viscosupplementation Market Is Booming Worldwide | Anika - openPR.com

Apr 02, 2025

Apr 01, 2025

Europe Viscosupplementation Market Projected To Witness - openPR.com

Apr 01, 2025

Mar 31, 2025

Anika Therapeutics stock hits 52-week low at $14.9 By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

Anika Therapeutics stock hits 52-week low at $14.9 - Investing.com India

Mar 31, 2025

Mar 29, 2025

How the (ANIK) price action is used to our Advantage - news.stocktradersdaily.com

Mar 29, 2025

Mar 29, 2025

Anika Therapeutics, Inc. (NASDAQ:ANIK) Stock Position Reduced by Charles Schwab Investment Management Inc. - Defense World

Mar 29, 2025

Mar 28, 2025

Hammertoe Solution Market Size, Trends 2031 By Key Players- - openPR.com

Mar 28, 2025

Mar 26, 2025

Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Acquired by Bank of New York Mellon Corp - Defense World

Mar 26, 2025

Mar 25, 2025

Europe Viscosupplementation Market Set to Witness Significant - openPR.com

Mar 25, 2025

Mar 23, 2025

Reviewing Anika Therapeutics (NASDAQ:ANIK) and InspireMD (NYSE:NSPR) - Defense World

Mar 23, 2025

Mar 18, 2025

Anika Therapeutics Faces Financial Strain Amid Geopolitical Tensions and Supply Chain Disruptions - TipRanks

Mar 18, 2025

Mar 17, 2025

Anika Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 17, 2025

Mar 17, 2025

Viscosupplementation Market Is Booming Worldwide | Anika Therapeutics Inc., Seikagaku Corporation - openPR.com

Mar 17, 2025

Mar 17, 2025

Q1 Earnings Forecast for ANIK Issued By Barrington Research - Defense World

Mar 17, 2025

Mar 16, 2025

Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2024 Earnings Call Transcript - MSN

Mar 16, 2025

Mar 15, 2025

Anika Therapeutics (NASDAQ:ANIK) Stock Rating Upgraded by StockNews.com - Defense World

Mar 15, 2025

Mar 15, 2025

Barrington Research Lowers Anika Therapeutics (NASDAQ:ANIK) Price Target to $20.00 - Defense World

Mar 15, 2025

Mar 14, 2025

Anika Therapeutics (NASDAQ:ANIK investor three-year losses grow to 45% as the stock sheds US$26m this past week - Simply Wall St

Mar 14, 2025

Mar 14, 2025

Anika Therapeutics Full Year 2024 Earnings: Misses Expectations - Yahoo Finance

Mar 14, 2025

Mar 13, 2025

Anika Therapeutics stock hits 52-week low at $15.34 By Investing.com - Investing.com Australia

Mar 13, 2025

Mar 13, 2025

Anika Therapeutics’ Earnings Call: Growth Amid Challenges - TipRanks

Mar 13, 2025

Mar 13, 2025

Anika Therapeutics stock hits 52-week low at $15.34 - Investing.com

Mar 13, 2025

Mar 13, 2025

Earnings call transcript: Anika Therapeutics Q4 2024 beats EPS forecast, stock dips - Investing.com Australia

Mar 13, 2025

Mar 13, 2025

Anika Therapeutics Inc (ANIK) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges - Yahoo Finance

Mar 13, 2025

Mar 12, 2025

Anika Therapeutics Reports Steady Growth and Strategic Focus - TipRanks

Mar 12, 2025

Mar 12, 2025

Earnings call transcript: Anika Therapeutics Q4 2024 beats EPS forecast, stock dips By Investing.com - Investing.com South Africa

Mar 12, 2025

Mar 12, 2025

Anika Therapeutics (ANIK) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Mar 12, 2025

Mar 12, 2025

Anika Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 12, 2025

Mar 12, 2025

Anika: Q4 Earnings Snapshot -March 12, 2025 at 04:34 pm EDT - Marketscreener.com

Mar 12, 2025

Mar 12, 2025

ANIKA THERAPEUTICS Earnings Results: $ANIK Reports Quarterly Earnings - Nasdaq

Mar 12, 2025

Mar 12, 2025

Anika Therapeutics Q4 Swings to Adjusted Loss, Revenue Rises -- Shares Drop After Hours - Marketscreener.com

Mar 12, 2025

Mar 12, 2025

Anika Therapeutics, Inc. Reports 2024 Financial Results with 17% Growth in Commercial Channel Revenue and Key Strategic Advances - Nasdaq

Mar 12, 2025

Mar 12, 2025

Anika Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire

Mar 12, 2025

Mar 12, 2025

Anika's Commercial Channel Soars 25% in Q4: Inside the Transformation Strategy - StockTitan

Mar 12, 2025

Mar 11, 2025

Anika Therapeutics Sells Parcus Medical to Medacta - TipRanks

Mar 11, 2025

Mar 10, 2025

Anika Therapeutics at CG 2025 Musculoskeletal Conference: Strategic Growth Unveiled - Investing.com Canada

Mar 10, 2025

Mar 10, 2025

Anika Therapeutics at CG 2025 Musculoskeletal Conference: Strategic Growth Unveiled By Investing.com - Investing.com South Africa

Mar 10, 2025

Mar 10, 2025

ANIKA THERAPEUTICS Earnings Preview: Recent $ANIK Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 10, 2025

Mar 09, 2025

Anika Therapeutics Reports Third-Quarter Financial Results - AOL

Mar 09, 2025

Mar 08, 2025

(ANIK) Investment Report - news.stocktradersdaily.com

Mar 08, 2025

Mar 07, 2025

Anika Therapeutics falls after its completes divestiture of Parcus Medical business - TradingView

Mar 07, 2025

Mar 07, 2025

Anika Completes Divestiture of Parcus Medical - citybiz

Mar 07, 2025

Mar 07, 2025

Anika Therapeutics Completes Divestiture of Parcus Medical to Medacta -March 07, 2025 at 06:38 am EST - Marketscreener.com

Mar 07, 2025

Mar 07, 2025

Anika Therapeutics (ANIK) Projected to Post Quarterly Earnings on Wednesday - MarketBeat

Mar 07, 2025

Mar 07, 2025

Anika Therapeutics Completes Sale of Parcus Medical to Medacta Group SA - Nasdaq

Mar 07, 2025

Mar 07, 2025

Can Anika's Strategic Exit from Parcus Medical Transform Its Growth Trajectory? - StockTitan

Mar 07, 2025